-
Sigyn Therapeutics Releases Letter to Shareholders
[ad_1] SAN DIEGO, CA – (NewMediaWire) – January 04, 2024 – Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a…
Read More » -
Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products
[ad_1] LAS VEGAS, NV – (NewMediaWire) – January 04, 2024 – BioAdaptives Inc. (OTC: BDPT), a leading manufacturer and distributor of…
Read More » -
News
LeapCharger Unveils Future of EV Charging: Home Solutions to Hit Supermarket Shelves in Dubai
[ad_1] CARSON CITY, NV – (NewMediaWire) – January 4, 2024 – LeapCharger Corporation (OTC: LCCN) (“LeapCharger” or the “Company”), an electric…
Read More » -
GeoVax Announces Gedeptin Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients
[ad_1] Therapy Demonstrated Safety, Stabilization/Shrinkage of Treated Tumors Expanded Development for Monotherapy and Combination Therapy Anticipated ATLANTA, GA – (NewMediaWire)…
Read More » -
News
DRIVEN BRANDS INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Driven Brands Investors of a Class Action Lawsuit and Upcoming Deadline
[ad_1] NEW YORK, NY – (NewMediaWire) – January 04, 2024 – Kaplan Fox & Kilsheimer LLP reminds investors that a…
Read More »